| EX0054 ALDOSTERONE, PLASMA |
| Specimen: |
3 mL (2.5 mL min.) plasma from 1 Lavender Top (EDTA) tube. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 8 hrs |
5 days |
4 weeks |
|
| Method: |
CLIA |
| Comment: |
A complete investigation of Aldosterone pathophysiology must include assessment of PLASMA RENIN DIRECT. |
| Report: |
Contact us to know the TAT. |
| Usage: |
This assay is useful in the investigation of Primary Aldosteronism (Adrenal Adenoma / Carcinoma and Adrenal Cortical Hyperplasia) and Secondary Aldosteronism (Renovascular disease, salt depletion, potassium loading, cardiac failure with ascites, and pregnancy). |
| Doctor Specialty: |
Endocrinologist |
| Disease: |
Disorders of Adrenal Gland |
| Components: |
|
| Courier Charges: |
0.00 |
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Biochemistry |
| Pre Test Information: |
The patient should be ambulatory/upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride, and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors, and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with the treating physician. |
Reviews
There are no reviews yet.